The Chemours Company
CC · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 6.83B | 1.62B | 786.00M | 578.00M | 3.72 |
| 2023 FY | 6.08B | 1.31B | -123.00M | -238.00M | -1.60 |
| 2024 FY | 5.78B | 1.15B | 443.00M | 86.00M | 0.58 |
| 2025 FY | 5.81B | 902.00M | -5.00M | -386.00M | -2.57 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 7.64B | 6.53B | 1.10B | 3.88B | 1.11B |
| 2023 FY | 8.25B | 7.51B | 1.20B | 4.30B | 737.00M |
| 2024 FY | 7.52B | 6.91B | 713.00M | 4.36B | 604.00M |
| 2025 FY | 7.38B | 7.13B | 672.00M | 4.59B | 250.00M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 755.00M | -307.00M | 448.00M | -154.00M | -247.00M |
| 2023 FY | 556.00M | -370.00M | 186.00M | -149.00M | 503.00M |
| 2024 FY | -633.00M | -360.00M | -993.00M | -148.00M | -1.04B |
| 2025 FY | 264.00M | -213.00M | 51.00M | -78.00M | -41.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 4.76B | 7.54B | — | — | — |
| 2023 FY | 4.70B | 7.79B | — | — | — |
| 2024 FY | 2.53B | 6.17B | — | — | — |
| 2025 FY | 1.77B | 5.69B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 1.62B | 278.00M | 72.00M | -381.00M | -2.54 |
| 2025 Q3 | 1.50B | 235.00M | 104.00M | 60.00M | 0.40 |
| 2025 Q4 | 1.33B | 153.00M | -259.00M | -61.00M | -0.40 |
| 2026 Q1 | 1.38B | 215.00M | 64.00M | -29.00M | -0.19 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 7.49B | 7.25B | 502.00M | 4.41B | 237.00M |
| 2025 Q3 | 7.57B | 7.27B | 613.00M | 4.42B | 298.00M |
| 2025 Q4 | 7.38B | 7.13B | 670.00M | 4.59B | 250.00M |
| 2026 Q1 | 7.27B | 7.05B | 563.00M | 4.39B | 215.00M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 93.00M | -43.00M | 50.00M | -13.00M | 39.00M |
| 2025 Q3 | 146.00M | -41.00M | 105.00M | -13.00M | 112.00M |
| 2025 Q4 | 137.00M | -45.00M | 92.00M | -15.00M | 59.00M |
| 2026 Q1 | -44.00M | -49.00M | -93.00M | -13.00M | -109.00M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 1.72B | 5.63B | — | — | — |
| 2025 Q3 | 2.38B | 6.18B | — | — | — |
| 2025 Q4 | 1.77B | 5.69B | — | — | — |
| 2026 Q1 | 3.31B | 7.14B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |